SFX by Ex Libris Inc.

Title:	Antiviral strategies against influenza virus: towards new therapeutic approaches
Source:	Cellular and Molecular Life Sciences [1420-682X] Loregian, Arianna yr:2014

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Santesso, N. "Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies." Influenza and other respiratory viruses 7.2 (2013): 76-81.
description	2.	Zambon, M. "Developments in the treatment of severe influenza: lessons from the pandemic of 2009 and new prospects for therapy." Current opinion in infectious diseases 27.6 (2014): 560-565.
description	3.	Król, E. "Antivirals - current trends in fighting influenza." Acta Biochimica Polonica 61.3 (2014): 495-504.
description	4.	Sapay, N. "Rebuilding a macromolecular membrane complex at the atomic scale: Case of the Kir6.2 potassium channel coupled to the muscarinic acetylcholine receptor M2." Proteins 82.9 (2014): 1694-1707.
description	5.	Preziosi, P. "Influenza pharmacotherapy: present situation, strategies and hopes." Expert opinion on pharmacotherapy 12.10 (2011): 1523-1549.
description	6.	Wang, K. "Neuraminidase inhibitors for preventing and treating influenza in children." Cochrane database of systematic reviews 1.1 (2012): 8965-.
description	7.	Michiels, B. "The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews." PLoS ONE 8.4 (2013): 60348-.
description	8.	Ebell, Mark H. "Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials." Family practice 30.2 (2012): 125-133.
description	9.	MOSCONA, A. "Oseltamivir-resistant influenza?" Lancet, The 364.9436 (2004): 733-734.
description	10.	Nicholson, M. "Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis." The Lancet infectious diseases 9.9 (2009): 537-45.
description	11.	Ludwig, S. "Influenza, a One Health paradigm—Novel therapeutic strategies to fight a zoonotic pathogen with pandemic potential." International journal of medical microbiology 304.7 (2014): 894-901.
description	12.	L'vov, D K. "The combination of ribavirin and ozeltamivir effectively inhibits reproduction of influenza A virus resistant to rimantadine (amantadine) in vitro and in vivo." Doklady biochemistry and biophysics 455.1 (2014): 80-3.
description	13.	Smit, E. "Antiviral resistance testing." Current opinion in infectious diseases 27.6 (2014): 566-572.
description	14.	Tran, L. "Recent progress and challenges in the computer-aided design of inhibitors for influenza A M2 channel proteins." Medicinal chemistry research 23.8 (2014): 3607-3616.
description	15.	Fineberg, Harvey V. "Pandemic preparedness and response--lessons from the H1N1 influenza of 2009." The New England journal of medicine 370.14 (2014): 1335-1342.
description	16.	McKimm Breschkin, Jennifer L. "Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance." Influenza and other respiratory viruses 7 Suppl 1.1 SUPPL.1 (2013): 25-36.
description	17.	Wong, K. "Epidemiology of 2009 Pandemic Influenza A Virus Subtype H1N1 Among Kenyans Aged 2 Months to 18 Years, 2009-2010." The Journal of infectious diseases 206 Suppl 1 (2012): -73.
description	18.	Wilson, Karen M. "Second-Hand Tobacco Smoke Exposure and Severity of Influenza in Hospitalized Children." The journal of pediatrics 162.1 (2012): 16-21.
description	19.	Widdowson, M. "Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study." The Lancet infectious diseases 12.9 (2012): 687-695.
description	20.	Soleimani, G. "Clinical presentation of novel influenza a (H1N1) in hospitalized children." Majallah-i bīmārīhā-yi kūdakān-i Īrān 21.2 (2011): 200-204.